MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® – the first and only FDA-approved once-daily amoxicillin.
Company Details
- Employees
- 26
- Founded
- -
- Address
- 7 Village Circle,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.middlebrookpharma.com
- HQ
- Westlake, TX
Middlebrook Pharmaceuticals, Inc Questions
Middlebrook Pharmaceuticals, Inc's website is http://www.middlebrookpharma.com
Middlebrook Pharmaceuticals, Inc's LinkedIn profile is https://www.linkedin.com/company/middlebrook-pharmaceuticals-inc
Middlebrook Pharmaceuticals, Inc has
26 employees.
View email and phone details for 26
employees at Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc's industry is
Pharmaceutical Manufacturing
Middlebrook Pharmaceuticals, Inc's top competitors are
Glg,
Parafill Pharmacy,
Health & Beauty Zone,
Aging Matters,
Karuna Therapeutics,
Jolly's Pharmaceuticals (Otcs) & Medical Devices Sales,
Bellicum Pharmaceuticals, Inc.,
Dicerna Pharmaceuticals, Inc.,
Cintas,
Sereno Pharmaceuticals Llc.
Middlebrook Pharmaceuticals, Inc's categories are Pharmaceutical Manufacturing
Middlebrook Pharmaceuticals, Inc's founding year is 2000
